tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
US Market

Sarepta Therapeutics (SRPT) Technical Analysis

Compare
3,195 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Sarepta Therapeutics’s (SRPT) Moving Averages Convergence Divergence (MACD) indicator is -9.70, suggesting Sarepta Therapeutics is a Buy.
Sarepta Therapeutics’s (SRPT) 20-Day exponential moving average is 87.46, while Sarepta Therapeutics’s (SRPT) share price is $71.81, making it a Sell.
Sarepta Therapeutics’s (SRPT) 50-Day exponential moving average is 100.01, while Sarepta Therapeutics’s (SRPT) share price is $71.81, making it a Sell.

Sarepta Therapeutics (SRPT) Pivot Points

Mar 28, 2025, 12:55 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
67.57
69.24
71.06
72.73
74.55
76.22
78.04
Fibonacci
69.24
70.57
71.40
72.73
74.06
74.89
76.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sarepta Therapeutics (SRPT) Moving Averages

Mar 28, 2025, 12:55 PM
Period
Simple
Exponential
MA5
73.75Sell
74.36Sell
MA10
79.42Sell
79.36Sell
MA20
90.99Sell
87.46Sell
MA50
103.82Sell
100.01Sell
MA100
112.77Sell
109.26Sell
MA200
123.99Sell
118.72Sell
Sarepta Therapeutics’s (SRPT) 10-Day exponential moving average is 79.36, while Sarepta Therapeutics’s (SRPT) share price is $71.81, making it a Sell.
Sarepta Therapeutics’s (SRPT) 100-Day exponential moving average is 109.26, while Sarepta Therapeutics’s (SRPT) share price is $71.81, making it a Sell.
Sarepta Therapeutics’s (SRPT) stock price is $71.81 and Sarepta Therapeutics’s (SRPT) 50-day simple moving average is 103.82, creating a Sell signal.
Sarepta Therapeutics’s (SRPT) stock price is $71.81 and Sarepta Therapeutics’s (SRPT) 100-day simple moving average is 112.77, creating a Sell signal.
Sarepta Therapeutics’s (SRPT) stock price is $71.81 and Sarepta Therapeutics’s (SRPT) 200-day simple moving average is 123.99, creating a Sell signal.

Sarepta Therapeutics (SRPT) Technical Indicators

Mar 28, 2025, 12:55 PM
Name
Value
Implied Action
RSI (14)
28.20
Buy
STOCH (9,6)
4.49
Buy
STOCHRSI (14)
4.23
Buy
MACD (12,26)
-9.70
Buy
ADX (14)
41.97
Neutral
Williams %R
-97.22
Buy
CCI (14)
-96.71
Neutral
ATR (14)
5.14
-
Ultimate Oscillator
40.84
Neutral
ROC
-30.30
Sell
Sarepta Therapeutics’s (SRPT) Relative Strength Index (RSI) is 28.20, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) Trend Strength Indicator (ADX) is 41.97, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Commodity Channel Index (CCI) is -96.71, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Price Rate of Change (ROC) is -30.30, creating a Sell signal.

FAQ

Is SRPT a Buy, Hold, or Sell?
Based on SRPT’s technical indicators, SRPT is a Sell.
    What is SRPT’s RSI (14)?
    SRPT’s RSI (14) is 28.20, which suggests SRPT is a Buy.
      What is SRPT’s MACD?
      SRPT’s MACD is -9.70, which suggests SRPT is a Buy.
        What is SRPT’s 5-day moving average?
        SRPT’s 5-day moving average is 73.75, which suggests SRPT is a Sell.
          What is SRPT’s 20-day moving average?
          SRPT 20-day moving average is 90.99, which suggests SRPT is a Sell.
            What is SRPT’s 50-day moving average?
            SRPT’s 50-day moving average is 103.82, which suggests SRPT is a Sell.
              What is SRPT’s 200-day moving average?
              SRPT’s 200-day moving average is 123.99, which suggests SRPT is a Sell.
                What is SRPT’s Williams % R (14)?
                SRPT’s Williams % R (14) is -97.22, which suggests SRPT is a Buy.
                  What is SRPT’s CCI (14)?
                  SRPT’s CCI (14) is -96.71, which suggests SRPT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis